Alliance Pharma buys Lypsyl from Novartis

18 December 2013 - Deborah Wilkes

Archived

Alliance Pharma has acquired all rights to Lypsyl in the UK and Ireland from Novartis for US$3.0 million.

Click tags below for more information on topics:

Alliance Pharma

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: